





























Serum phosphorus levels are associated with carotid intima-media
thickness in asymptomatic postmenopausal women
Hyeongsoo Kim, MD,1 Jeong Sook Kim, MD,2 SiHyun Cho, MD, PhD,3,4 and Jong-Youn Kim, MD, PhD5
Abstract
Objective: Serum phosphorous is a significant risk factor for increased carotid intima-media thickness. Increased
thickness of the carotid intima is a known cause of cardiovascular disease. Coronary heart disease is a significant cause
of mortality and morbidity in postmenopausal women. This study aimed to compare the relationship between serum
phosphorous concentration and carotid intima-media thickness in healthy asymptomatic postmenopausal women.
Methods: A retrospective review of the medical records from a health checkup center in Gangnam Severance
hospital between March 2007 and September 2017 was conducted. We examined asymptomatic postmenopausal
female patients with age range between 56 and 66 (N¼ 361) who underwent measurement of carotid intima-media
thickness by B-mode ultrasonography. The physiological variables analyzed included mean blood pressure, body
mass index, renal function (serum creatinine and estimated glomerular filtration rate), cholesterol levels (total
cholesterol, triglyceride, and high- and low-density lipoprotein), serum phosphorous, calcium, electrolytes, diabetic
status, hypertension, and albumin.
Results: Pearson correlation test showed that carotid intima-media thickness was significantly associated with
age (r¼ 0.192, P< 0.001), mean blood pressure (r¼ 0.116, P¼ 0.029), diastolic blood pressure (r¼ 0.146,
P¼ 0.029), serum phosphorous (r¼ 0.134, P¼ 0.012), and lactate dehydrogenase (r¼ 0.106, P¼ 0.047). On
the basis of age-adjusted multivariate linear regression analysis, carotid intima-media thickness was significantly
correlated with serum phosphorous levels (b¼ 0.273, P¼ 0.022) in asymptomatic menopausal women. Increased
carotid intima-media thickness (cut-off 1.5 mm) was detected, although serum phosphorous was within the normal
range (2.8-4.5 mg/dL).
Conclusions: Serum phosphorus concentration is significantly associated with carotid intima-media thickness in
asymptomatic menopausal women.
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C
oronary heart disease is the leading cause of mor-
tality and morbidity in postmenopausal women. A
high serum phosphorous level has been associated
with increased mortality from cardiovascular disease
(CVD) in patients who experience chronic kidney dis-
ease.1,2 Although within the normal range, the serum
phosphorous level is indicated as an independent factor
of increased mortality risk for patients with CVD.3 In
another study, serum phosphorous levels within the normal
range showed a significant correlation with carotid intima-
media thickness (CIMT) in asymptomatic young adults.
Moreover, the phosphorous levels may be a potentially
modifiable risk factor for stroke and death within the
general population.4
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In a 1960s study, the serum phosphorous levels in men and
women differed with progressive aging. From the age of 20 to
60 years, men experience a progressive decrease in serum
phosphate levels. Although premenopausal women show a
similar decrease in serum phosphate level, the serum phos-
phate levels increase after menopause.5 A few studies have
elucidated the relationship between serum phosphorous level
and coronary heart problems in postmenopausal women.
In this study, we hypothesized that the serum phosphorous
concentration is a marker for CVD in asymptomatic post-
menopausal women. To identify the factors associated with
CIMT, we compared the relationship between serum phos-
phorous levels and CIMT in asymptomatic postmenopausal
women compared with physiological functions. This study
aimed to determine the effects of altered serum phosphorus
levels on cardiovascular events in postmenopausal women.
The carotid artery intima-media thickness is a validated
indicator of subclinical atherosclerosis and future CVD risk.6-8
METHODS
Patients
A retrospective review of the medical records of asymp-
tomatic postmenopausal female patients with age range
between 56 and 66 (N¼ 361) who were not diagnosed with
coronary heart disease or a metabolic disorder such as hypo/
hyperparathyroidism previously was conducted. The meas-
urements of CIMT by B-mode ultrasonography were recorded
between March 2007 and September 2017 for all routine
health checkups at Gangnam Severance Hospital, Korea. All
women signed informed consent forms. This retrospective
study was conducted in accordance with the ethical standards
of the Helsinki Declaration and was approved by the institu-
tional review board of Yonsei University Health System,
Gangnam Severance Hospital. Of the 361 eligible partici-
pants, 4 patients were excluded due to missing information
and another 4 were excluded due to errors in recording their
age at the onset of menopause. Thus, a total of 353 partic-
ipants were included without any missing data in the study.
Carotid ultrasonography
The carotid arteries were evaluated by a standardized
protocol.9 The ultrasonographic images were acquired in
end diastole (defined as the R wave of an electrocardiogram)
by sonographers certified by the Registry of Diagnostic
Cardiac Sonographers, and they were equipped with an
11 MHz imaging transducer (iU22 or EPIQ 5 [Philips, And-
over, MA]). With the participants in the supine position and
with slight hyperextension of the neck, the common carotid
artery, internal carotid artery, and external carotid artery
including carotid bulb and vertebral arteries were identified.
All carotid measurements were performed using a semiauto-
mated vessel-wall detection software. Following short-axis
2D image acquisition of the common carotid artery (CCA),
long-axis B-mode ultrasound images were acquired for
subsequent measurements. Carotid measurements included
intima-media thickness of the far vessel wall at a site
approximately 1 cm proximal to the carotid bulb. The aver-
aged intima-media thickness (IMT) values of the left and right
CCAs were subsequently used in all analyses. Plaque was
defined as protrusion of the vessel wall into the arterial lumen
of at least 0.5 mm, with an IMT 50% of the IMT of the
surrounding sites or an IMT >1.5 mm. The peak systolic
velocity and end diastolic velocity were measured in the CCA,
external carotid artery, and internal carotid artery using a
semiautomatic analysis system.
Other variables
The participants were instructed to fast for 8 to 10 hours
before screening, and compliance was determined by an
interview before examination. Height and weight were mea-
sured twice. Body mass index (BMI) was calculated as weight
in kilograms divided by the square of the height in meters.
Blood pressure was measured using mercury sphygmoman-
ometers on the right arm of the participants in a relaxed sitting
position by two randomly assigned nurses (three replicates
each). The first and fifth Korotkoff sounds were used to
determine the systolic (sBP) and diastolic blood pressure
(dBP), respectively. The mean blood pressure (MBP) was
estimated as a function of the sBP and dBP [(sBPþ 2 dBP)/3].
The serum phosphorous levels were measured using the
ammonium molybdate method, as part of the multiple chem-
istry profile (SMA 20) using the multichannel Olympus Au-
5000 Analyzer (Olympus, Lake Success, NY). The serum
levels of cholesterol and triglycerides were determined enzy-
matically on a Hitachi 902 Automatic analyzer (Roche Diag-
nostics, Indianapolis, IN). The chemistry tests including fasting
glucose, creatinine, uric acid, blood urea nitrogen, serum
calcium, total protein, albumin, total bilirubin, alkaline phos-
phatase, aspartate aminotransferase, lactate dehydrogenase
(LDH), and gamma glutamyl transferase were measured using
Atellica CH 930 (Siemens, Erlangen, Germany). The estimated
glomerular filtration rate (eGFR) was estimated as a function of
age, serum creatinine, sex, and race using the simplified
modification of diet in renal disease equation: (mm/min/
1.73 m2)¼ 186.3 creatinine 1.154 age 0.203 (0.742
if the patient was a woman) (1.21 if the patient was of
African descent), where m2 denotes the body surface area in
square meters.
Statistical analysis
Continuous or categorical variables were described as
mean standard deviation or number percentage. The age
adjusted correlation of continuous variables was examined by
the partial Pearson correlation coefficient test. A multivari-
able stepwise regression analysis was performed to find the
independent CIMT predictors, including 15 variables; age,
MBP, BMI, phosphorous, uric acid, aspartate aminotransfer-
ase (AST), LDH, low-density lipoprotein, estimated glomer-
ular filtration rate, number of births, smoking history,
hypertension, diabetes mellitus, history of cancer, and history
of hormonal treatment. The null hypothesis was rejected for
P< 0.05.
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111All computations relied on standard software (SPSS
v23; SPSS Inc [IBM], Chicago, IL).
RESULTS
A total of 353 women were analyzed. The mean age was
61.45 7.41 years, whereas the mean BMI was 24.04
4.02 kg/m2 and the MBP was 94.74 11.6 mmHg. There were
129 women (36.5%) with hypertension and 22 women (6.2%)
with diabetes mellitus. The mean maximum CIMT was
1.56 1.6 mm (Table 1). The biochemical characteristics
are shown in Table 2. The mean total cholesterol and low-
density lipoprotein cholesterol levels were 211.6 41.26
and 136.07 38.5 mg/dL, respectively. The mean eGFR
was 94.44 12.8 mL/min/1.73 m2; serum uric acid level,
4.67 1.04 mg/dL; serum phosphorus level, 3.98 0.7 mg/dL;
and serum calcium level, 9.23 0.43 mg/dL. The AST and
LDH levels were 27.38 14.37 and 384.17 71.69 IU/L,
respectively (Table 2).
The analysis of Pearson correlations between the mean
CIMT and clinical parameters showed that age (r¼ 0.192,
P< 0.001), MBP (r¼ 0.116, P¼ 0.029), dBP (r¼ 0.146,
P¼ 0.029), serum phosphorus level (r¼ 0.134, P¼ 0.012),
and serum LDH level (r¼ 0.106, P¼ 0.047) were signifi-
cantly associated with the mean CIMT (Table 3).
The univariate regression analysis results are shown in
Table 4. Age, MBP, serum phosphorous level, LDH level,
eGFR, and a history of hormonal treatment were associated
with CIMT; these associations were clinically significant. In
multivariate regression analysis, age (b¼ 0.038, P¼ 0.001),
MBP (b¼ 0.021, P¼ 0.004), serum phosphorus level (b¼
0.273, P¼ 0.022), serum AST level (b¼ 0.012, P¼ 0.034),
and a history of hormonal treatment (b¼ 0.609, P¼ 0.014)
were significant and independent explanatory variables for
the mean CIMT. The adjusted R2 and Akaike information
criterion were 0.09 and 1302.1, respectively (Table 4).
The scatter plot in Figure 1 shows a positive correlation
between CIMT and serum phosphorous level. The serum
phosphorous level was 3.7 mg/dL for a CIMT of 1.5 mm.




Age, y 61.45 7.41
Menopause age, y 50.22 4.25
Menopausal duration, y 11.24 7.89
Menarche age, y 14.20 0.75
BMI, kg/m2 24.04 4.02
Mean blood pressure, mmHg 94.74 11.56
Systolic blood pressure, mmHg 129.4 16.7
Diastolic blood pressure, mmHg 77.41 10.13
No. pregnancies 1.57 2.21
No. births 1.05 1.36
No. abortions 0.67 1.24
History of alcohol 100 (28.3%)
Smoker 18 (5.1%)
Regular exercise 230 (65.2%)
Thyroid disease 94 (26.6%)
Hypertension 129 (36.5%)
Diabetes mellitus 22 (6.2%)
History of hysterectomy 18 (5.1%)
History of cancer 22 (6.2%)
Hormonal treatment 44 (12.5%)
Carotid intima-media thickness (mm) maximum value 1.56 1.6
BMI, body mass index; No., number; SD, standard deviation.
TABLE 2. Biochemical characteristics in postmenopausal women
Variables (N¼ 353) Mean standard deviation
Total cholesterol, mg/dL 211.6 41.3
TG, mg/dL 128.98 68.7
HDL, mg/dL 56.77 13.0
LDL, mg/dL 136.07 38.5
Fasting glucose 101.96 16.5
eGFR, mL/min/1.73 m2 94.44 12.8
Serum creatinine, mg/dL 0.66 0.14
BUN, mg/dL 14.52 3.3
Uric acid, mg/dL 4.67 1.0
Phosphorous, mg/dL 3.98 0.7
Calcium, mg/dL 9.23 0.4
Total protein, g/dL 7.28 0.4
Albumin, mg/dL 4.59 0.3
Total bilirubin, mg/dL 0.78 0.3
Alkaline phosphatase 77.86 22.9
AST, IU/L 27.38 14.4
Gamma GT 24.03 18.3
LDH, IU/L 384.17 71.7
AST, aspartate aminotransferase; BUN, blood urea nitrogen; eGFR, estimated
glomerular filtration rate; GT, glutamyl transferase; HDL, high-density
lipoprotein cholesterol; LDH, lactate dehydrogenase; LDL, low-density
lipoprotein cholesterol; TG, triglyceride.
TABLE 3. Pearson correlation analysis of the carotid intima-media
thickness with the covariates
Variables Pearson correlation coefficient P
Age, y 0.192 <0.001a
Menopause age, y 0.023 0.667
Menopausal duration, y 0.023 0.667
Menarche age, y 0.002 0.970
BMI, kg/m2 0.060 0.258
Mean blood pressure, mmHg 0.116 0.029b
Systolic blood pressure, mmHg 0.063 0.239
Diastolic blood pressure, mmHg 0.146 0.029b
Total cholesterol 0.020 0.707
TG, mg/dL 0.021 0.689
HDL, mg/dL 0.022 0.680
LDL, mg/dL 0.022 0.680
Fasting glucose, mg/dL 0.029 0.593
eGFR, mL/min/1.73 m2 0.022 0.684
Phosphorous, mg/dL 0.134 0.012b
Uric acid, mg/dL 0.082 0.125
Calcium, mg/dL 0.002 0.970
Total protein, g/dL 0.079 0.137
Albumin, mg/dL 0.064 0.230
Total bilirubin, mg/dL 0.002 0.966
Alkaline phosphatase, IU/L 0.032 0.554
AST, IU/L 0.099 0.063
Gamma GT, IU/L 0.029 0.586
LDH, IU/L 0.106 0.047b
AST, aspartate aminotransferase; BMI, body mass index; BUN, blood
urea nitrogen; CIMT, carotid intima-media thickness; eGFR, estimated
glomerular filtration rate; GT, glutamyl transferase; HDL, high-density
lipoprotein cholesterol; LDH, lactate dehydrogenase; LDL, low-density
lipoprotein cholesterol; TG, triglyceride.
aExcept for age, the other variables were adjusted for age to analyze with
CIMT by Pearson correlation.
bStatistically significant, P< 0.05.
KIM ET AL
1044 Menopause, Vol. 27, No. 9, 2020  2020 The Author(s)
DISCUSSION
In humans, serum phosphorous and calcium play important
roles in energy production, storage, and signaling.10 The
increase in the levels of minerals in the extracellular space
affect the vascular smooth muscle cells. This can lead to
atherosclerosis and vascular calcification.11 Among noninva-
sive image analysis, CIMT is well-known as an indicator and
surrogate of cardiovascular health status. CIMT has emerged
as an important tool for the prediction of cardiovascular and
stroke risk stratification because it is precisely reflective of
atherosclerosis, which is associated with future cardiovascu-
lar and stroke events.4,6,8,12-14
When women become menopausal, the estrogen levels
decrease rapidly; therefore, the associated risk of progression
to subclinical atherosclerosis can increase in these women, as
suggested in the studies by Lerner et al.15
Previous studies have reported that CIMT is significantly
correlated with serum phosphorous level; an increased serum
phosphorus level is a well-known indicator of increased risk for
ischemic stroke.4,16 Our results were similar to those of several
previous studies because CIMT was significantly associated
with serum phosphorous level after adjusting for age.
As age increases, serum phosphorous level changes. In our
data analysis, we performed Pearson correlation analysis by
TABLE 4. Linear regression analysis results (univariate and multivariate analysis)
Univariable Multivariable
Variable Estimate (SE) P Estimate (SE) P
Age, y 0.041 (0.011) <0.001 0.038 (0.011) 0.001
Mean blood pressure, mmHg 0.021 (0.007) 0.005 0.021 (0.007) 0.004
BMI, kg/m2 0.011 (0.021) 0.609 0.040 (0.021) 0.059
Phosphorous, mg/dL 0.254 (0.122) 0.038 0.273 (0.119) 0.022
Uric acid, mg/dL 0.146 (0.081) 0.071
AST, IU/L 0.011 (0.006) 0.066 0.012 (0.006) 0.034
LDH, IU/L 0.003 (0.001) 0.005
LDL, mg/dL 0.000 (0.002) 0.859
eGFR, mL/min/1.73 m2 0.013 (0.007) 0.050
No. births 0.100 (0.062) 0.104 0.095 (0.062) 0.129
Smoker 0.367 (0.382) 0.338
Hypertension 0.251 (0.174) 0.151
Diabetes mellitus 0.217 (0.348) 0.533
History of cancer 0.345 (0.348) 0.321 0.529 (0.342) 0.123
Hormonal treatment 0.548 (0.253) 0.031 0.609 (0.246) 0.014
Adjusted R2 0.09, AIC: 1302.1
AIC, Akaike information criterion; AST, aspartate aminotransferase; BMI, body mass index; eGFR, estimated glomerular filtration rate; LDH, lactate
dehydrogenase; LDL, low-density lipoprotein; No., number.
FIG. 1. Correlation scatter plot between CIMT and serum phosphorous levels. CIMT, carotid intima-media thickness.
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adjusting for age. The age-adjusted results showed that the
serum phosphorous level was significantly associated with
CIMT as well as with MBP, dBP, and serum LDH levels.17,18
Based on the results of a previous study, the CIMT cut-off
for atherosclerosis is determined as 1.5 mm. When the CIMT
is greater than 1.5 mm, the hazard ratio increases to more than
two times above the baseline.19,20 In our study, a correlation
scatter plot showed that at a CIMT of 1.5 mm, the serum
phosphorous level was 3.7 mg/dL, which is classified
within the normal serum phosphorous levels (normal range:
2.8-4.5 mg/dL). In asymptomatic postmenopausal women,
even when the serum phosphorous levels are within the
normal range, cardiac disease should be suspected for serum
phosphorous levels greater than 3.7 mg/dL.
LIMITATIONS
There are some limitations of our study. First, the data were
collected retrospectively with only data from a single health
center. Moreover, the sample size was small, and long-term
follow-up data were not included. Data for cardiovascular
events were also not collected. In future studies, we aim to
achieve statistical power, which can confirm cardiovascular
events, by collecting long-term follow-up data continuously.
Previous studies have reported that CIMT decreased in
patients undergoing hormonal treatment.21,22 Our data, how-
ever, showed the opposite trend, because only 12.5% of the
women included in the study received hormonal treatment.
Therefore the results of the study cannot be generalized.
CIMT is known to be affected by several factors. In our
study, the predicting value is 9%, which shows a relatively
low prediction rate.
CONCLUSIONS
This is the first study to report the association between
serum phosphorous levels and CIMT in asymptomatic post-
menopausal women. Our study identified the factors that
relate to the variation of CIMT, which is related to cardio-
vascular risk. Age, MBP, serum phosphorus level, serum AST
level, and a history of hormonal treatment were significantly
associated with CIMT. In asymptomatic menopausal women,
even when the serum phosphorous levels are within the
normal range, cardiac disease should be suspected at levels
above 3.7 mg/dL.
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